Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Genevieve Saphier"'
Autor:
Sulagna Ghosh, Seva Kashin, Shila Mekhoubad, Nissim Benvenisty, Kevin Eggan, Genevieve Saphier, Curtis J. Mello, Florian T. Merkle, Maura Charlton, Steven A. McCarroll, Yishai Avior, Nolan Kamitaki, Robert E. Handsaker, Shiran Bar, Jana M. Mitchell, Giulio Genovese, Dusko Ilic
Publikováno v:
Nature. 545:229-233
Human pluripotent stem cells (hPS cells) can self-renew indefinitely, making them an attractive source for regenerative therapies. This expansion potential has been linked with the acquisition of large copy number variants that provide mutated cells
Publikováno v:
CourseSource. 3
Autor:
Hiroshi Mitsumoto, Kevin Eggan, Genevieve Saphier, Kathy K. Niakan, Rudy Leibel, Laurin M. Weisenthal, Kit T. Rodolfa, John T. Dimos, Robin Goland, Wendy K. Chung, Christopher E. Henderson, Hynek Wichterle, Gist F. Croft
Publikováno v:
Science. 321:1218-1221
The generation of pluripotent stem cells from an individual patient would enable the large-scale production of the cell types affected by that patient's disease. These cells could in turn be used for disease modeling, drug discovery, and eventually a
Autor:
Robin Goland, William G. Kearns, Claire Fitzgerald, Jay B. Patel, Justin K. Ichida, Manfred Baetscher, Kevin Eggan, Kathryn J. Go, Rudolph L. Leibel, Alice E. Chen, Dieter Egli, Nicole Acevedo, Genevieve Saphier, Douglas A. Melton
Publikováno v:
Nature Communications. 2
Fertilized mouse zygotes can reprogram somatic cells to a pluripotent state. Human zygotes might therefore be useful for producing patient-derived pluripotent stem cells. However, logistical, legal and social considerations have limited the availabil
Autor:
Robin Goland, Rudolph L. Leibel, Genevieve Saphier, Michael M. Alper, Brian M. Berger, Kevin Eggan, Douglas Powers, Dieter Egli, Douglas A. Melton, Karin Katz, Alice E. Chen
Publikováno v:
Cell Stem Cell. (4):293-294
We thank a remarkable, anonymous woman for donating her oocytes. This work was supported by the Stowers Medical Institute, the Harvard Stem Cell Institute, the Naomi Berrie Diabetes Center, and the New York Stem Cell Foundation.